| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $333,517 ) |
| 2024 | 2024 | THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 000 | 7 | 12/20/2023 | NON-COMPETING CONTINUATION | $333,517 |
|
| Issue Date FY: 2023 ( Subtotal = $363,165 ) |
| 2023 | 2023 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 000 | 6 | 1/30/2023 | EXTENSION WITH OR WITHOUT FUNDS | $333,518 |
| 2023 | 2023 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 001 | 6 | 3/15/2023 | EXTENSION WITH OR WITHOUT FUNDS | $29,647 |
|
| Issue Date FY: 2022 ( Subtotal = $376,564 ) |
| 2022 | 2022 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 001 | 5 | 1/4/2022 | SUPPLEMENT FOR EXPANSION | $9,953 |
| 2022 | 2022 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 000 | 5 | 12/30/2021 | NON-COMPETING CONTINUATION | $329,400 |
| 2022 | 2022 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 003 | 5 | 5/26/2022 | SUPPLEMENT FOR EXPANSION | $611 |
| 2022 | 2022 | UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 002 | 5 | 5/26/2022 | NON-COMPETING CONTINUATION | $36,600 |
|
| Issue Date FY: 2021 ( Subtotal = $444,653 ) |
| 2021 | 2021 | UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD UNIT 207 | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 001 | 4 | 2/9/2021 | NON-COMPETING CONTINUATION | $22,234 |
| 2021 | 2021 | UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD UNIT 207 | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 000 | 4 | 12/30/2020 | NON-COMPETING CONTINUATION | $422,419 |
|
| Issue Date FY: 2020 ( Subtotal = $400,417 ) |
| 2020 | 2020 | UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD UNIT 207 | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 000 | 3 | 1/7/2020 | NON-COMPETING CONTINUATION | $366,000 |
| 2020 | 2020 | UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD UNIT 207 | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 001 | 3 | 9/17/2020 | SUPPLEMENT FOR EXPANSION | $34,417 |
|
| Issue Date FY: 2019 ( Subtotal = $355,019 ) |
| 2019 | 2019 | UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD UNIT 207 | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 000 | 2 | 1/31/2019 | NON-COMPETING CONTINUATION | $355,019 |
|
| Issue Date FY: 2018 ( Subtotal = $366,000 ) |
| 2018 | 2018 | UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD UNIT 207 | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 000 | 1 | 12/28/2017 | NEW | $366,000 |
| 2018 | 2018 | UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD UNIT 207 | HOUSTON | TX | 77030 | HARRIS | USA | Cancer Treatment Research | 001 | 1 | 7/19/2018 | NEW | $0 |
|
|